Zürcher Nachrichten - Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

EUR -
AED 4.256248
AFN 76.490971
ALL 92.792124
AMD 422.44687
ANG 2.07427
AOA 1062.75707
ARS 1732.616553
AUD 1.63944
AWG 2.086111
AZN 1.994262
BAM 1.958344
BBD 2.334573
BDT 141.413674
BGN 1.966004
BHD 0.437066
BIF 3463.385781
BMD 1.15895
BND 1.480962
BOB 13.416426
BRL 6.041378
BSD 1.159126
BTN 110.850499
BWP 15.646593
BYN 3.525564
BYR 22715.425801
BZD 2.331218
CAD 1.608574
CDF 2630.817445
CHF 0.939851
CLF 0.027192
CLP 1070.221371
CNY 7.815148
CNH 7.813087
COP 3598.401595
CRC 520.674028
CUC 1.15895
CUP 30.712183
CVE 110.406496
CZK 24.190302
DJF 206.411659
DKK 7.475902
DOP 68.088142
DZD 154.035311
EGP 58.498248
ERN 17.384254
ETB 187.506533
FJD 2.561856
FKP 0.855763
GBP 0.855647
GEL 3.018996
GGP 0.855763
GHS 12.808692
GIP 0.855763
GMD 85.761892
GNF 10182.181139
GTQ 8.841446
GYD 242.506024
HKD 9.090841
HNL 31.078232
HRK 7.534797
HTG 151.620857
HUF 365.893933
IDR 20661.765877
ILS 3.46671
IMP 0.855763
INR 110.922611
IQD 1518.491938
IRR 1593064.10296
ISK 142.214963
JEP 0.855763
JMD 183.15421
JOD 0.821676
JPY 184.55878
KES 150.089338
KGS 101.350078
KHR 4689.211939
KMF 493.712694
KPW 1043.055607
KRW 1619.407026
KWD 0.357872
KYD 0.96595
KZT 535.353031
LAK 26123.155315
LBP 103798.570367
LKR 384.743041
LRD 210.382346
LSL 18.804348
LTL 3.422078
LVL 0.701037
LYD 7.38572
MAD 10.769935
MDL 19.994884
MGA 4992.570729
MKD 61.605015
MMK 2432.921723
MNT 4168.919085
MOP 9.364484
MRU 46.487179
MUR 54.447114
MVR 17.916871
MWK 2009.980023
MXN 19.771605
MYR 4.708772
MZN 74.062734
NAD 18.804267
NGN 1564.860938
NIO 42.647849
NOK 10.899064
NPR 177.360599
NZD 1.974069
OMR 0.445616
PAB 1.159105
PEN 3.903904
PGK 5.208743
PHP 71.65439
PKR 321.689776
PLN 4.326849
PYG 6993.203764
QAR 4.236985
RON 5.242977
RSD 117.314761
RUB 98.39405
RWF 1707.977346
SAR 4.342108
SBD 9.301517
SCR 16.064083
SDG 697.102722
SEK 11.043122
SGD 1.479823
SHP 0.858627
SLE 28.568026
SLL 24302.607335
SOS 662.483328
SRD 44.001839
STD 23987.931215
STN 24.531757
SVC 10.142085
SYP 15068.671639
SZL 18.790731
THB 38.397149
TJS 10.710165
TMT 4.056326
TND 3.394594
TOP 2.790474
TRY 55.554972
TTD 7.860277
TWD 36.971708
TZS 3068.872573
UAH 51.924438
UGX 4323.634381
USD 1.15895
UYU 46.760533
UZS 13700.913572
VES 894.219218
VND 30340.159798
VUV 137.005872
WST 3.14759
XAF 656.832793
XAG 0.018496
XAU 0.000267
XCD 3.132121
XCG 2.08904
XDR 0.819438
XOF 656.821444
XPF 119.331742
YER 274.776137
ZAR 18.842579
ZMK 10431.945789
ZMW 21.646489
ZWL 373.181522
  • RBGPF

    0.3500

    69

    +0.51%

  • RYCEF

    -0.2500

    20.81

    -1.2%

  • CMSD

    -0.0900

    21.09

    -0.43%

  • BCE

    0.0100

    23.36

    +0.04%

  • BCC

    -1.7600

    80.18

    -2.2%

  • JRI

    -0.0400

    12.44

    -0.32%

  • CMSC

    -0.1200

    21.24

    -0.56%

  • RELX

    0.9500

    34.51

    +2.75%

  • BP

    0.5600

    43.41

    +1.29%

  • BTI

    0.6500

    56.38

    +1.15%

  • AZN

    3.2100

    160.1

    +2%

  • RIO

    -0.5200

    96.69

    -0.54%

  • GSK

    0.8700

    51.15

    +1.7%

  • NGG

    0.8600

    82.15

    +1.05%

  • VOD

    -0.0700

    16.13

    -0.43%

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management.

Text size:

ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios.

"Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 study sites globally - arming sponsors with portfolio-wide operational visibility so they can anticipate trial risk, act on insights, and drive execution on the ground."

Solving the $1 million per study problem

While digital-first sites set new standards for operational speed and efficiency, much of the industry still remains offline. Only 30% of global sites currently use an eISF, leaving roughly 200,000 sites dependent on inefficient paper processes for study startup, document collection and storage, regulatory process management, monitoring and closeout.

This lack of digitization costs sponsors an estimated $1 million per study in lost productivity, rework, quality and compliance risk.

Florence is closing this digital divide through the fastest growing clinical research network of 65,000 study sites and 600+ sponsors. By digitizing 100% of operational workflows, Florence sets the standard for startup speed, operational cost reduction, and risk control.

The results are compelling:

  • Up to 70% faster last mile study startup operations compared to the average site startup time for a Top 10 global pharmaceutical sponsor.

  • $141M annual operational cost takeout by automating site readiness workflows, based on active daily users and total hours saved per year across Florence's study site network.

  • 51% increase in eTMF QA pass rates from 65% to 98.7%, due to built-in operational audits and automated compliance checks to control risk.

Shaping the Future of Study Operations

Florence is embedding AI across the study lifecycle to unlock operational data intelligence, recommend next-best actions, strengthen risk control, and improve operating efficiency.

Site Identification & Feasibility

Drawing on the industry's largest network of site intelligence, Florence enables sponsors and CROs to identify the most qualified sites by therapeutic area, geography, and performance, while AI-assisted feasibility surveys ensure faster, more accurate completion.

Study Startup

AI-enabled contracting and document exchange between eTMF and eISF automates SSU document exchange, while generative AI redlining shortens contract review cycles, compares terms in seconds, and dramatically reduces time to activation.

Remote Monitoring

AI-powered reporting surfaces early risk signals from operational audit trails and site data, providing real-time visibility and enabling proactive intervention. These insights minimize the need for on-site visits and ensure trials stay on schedule.

Together, these advancements move sponsors and CROs from manual oversight to intelligent execution across global study portfolios. Through its open API network, Florence rapidly integrates and extends its trial operation capabilities to other eClinical partner systems.

Florence AI operates at the speed of trust, ensuring every study remains fully aligned with FDA, EMA, HIPAA, GDPR, EU Annex 11, ICH E6 (R3), and GCP standards.

All capabilities will be available in December 2025.

Join the Movement: Research Revolution 2025

Florence will showcase its newest capabilities at Research Revolution 2025, the company's annual global event (October 26-28, 2025) bringing together sponsors, CROs, and research sites. Be part of the global revolution. Watch it live at: https://researchrevolutionsummit.com/live/

About Florence Healthcare

Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

Contact Information

Seema Sheth-Voss
[email protected]
(888) 829-0896

SOURCE: Florence Healthcare



View the original press release on ACCESS Newswire

W.Odermatt--NZN